Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by WatchLearnEarnon Nov 10, 2017 2:48am

155 Views

Post# 26937640

RE:RE:Canadian standard treatment for Bladder cancer

Macer wrote:

It blows my mind that the market makes it look like the first part of phase one was a failure when they actually achived their endpoints.

Macer

Yep. Makes you wonder if TLT shot themselves in the foot by even reporting on an exploratory efficacy endpoint, which is not even required at this point.

TMI, Roger, TMI.

Bullboard Posts

Morning Market Outlook for Nov. 14, 2024